Literature DB >> 29531523

Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.

Paola Queirolo¹, Beatrice Dozin², Anna Morabito³, Barbara Banelli^3,4, Patrizia Piccioli⁵, Cristiana Fava¹, Claudio Leo¹, Roberta Carosio³, Stefania Laurent⁶, Vincenzo Fontana², Pier Francesco Ferrucci⁷, Chiara Martinoli⁷, Emilia Cocorocchio⁷, Angelo Battaglia⁷, Paolo A Ascierto⁸, Mariaelena Capone⁸, Ester Simeone⁸, Federica De Galitiis⁹, Elena Pagani⁹, Gian Carlo Antonini Cappellini⁹, Paolo Marchetti^9,10, Michele Guida¹¹, Stefania Tommasi¹¹, Mario Mandalà¹², Barbara Merelli¹², Pietro Quaglino¹³, Paolo Fava¹³, Massimo Guidoboni¹⁴, Massimo Romani³, Francesco Spagnolo¹, Maria Pia Pistillo³.

Abstract

[This corrects the article on p. 386 in vol. 8, PMID: 28446908.].

Entities: Chemical Disease Gene Species

Keywords: CTLA-4 variants; best overall response; ipilimumab; melanoma; overall survival; predictive/prognostic factor

Year: 2018 PMID： 29531523 PMCID： PMC5840259 DOI： 10.3389/fimmu.2018.00403

Source DB: PubMed Journal: Front Immunol ISSN： 1664-3224 Impact factor: 7.561

In the original article, affiliation number 9 was wrong. The correct affiliation 9 is “Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy”. This error does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

1 in total

1. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.

Authors: Xia Li; Yunpeng Cai
Journal: Aging (Albany NY) Date: 2020-08-28 Impact factor: 5.682

1 in total